Medical Condition News

RSS

Results of BATTLE Trial presented at AACR 2010

Lung cancer is the number one cause of cancer death in men and women, but huge randomized trials of thousands of patients have either failed completely or shown negligible survival differences.

19 Apr 2010

Cell Therapeutics receives feedback regarding proposed filing of MAA for pixantrone

Cell Therapeutics, Inc. today announced that it met with and received feedback from the rapporteurs and the European Medicines Agency's medical reviewers regarding a proposed filing of a Marketing Authorization Application for pixantrone in the European Union to treat relapsed/refractory aggressive non-Hodgkin's lymphoma.

19 Apr 2010

Organogenesis to showcase study results of Apligraf product at SAWC / WHS 2010

Organogenesis, Inc. will have a substantial presence at the 23rd Annual Symposium on Advanced Wound Care and Wound Healing Society being held April 17-20 in Orlando, FL. Results from several clinical and scientific studies will be presented which will further the understanding of Organogenesis' bilayered living cellular construct technology.

19 Apr 2010

Study evaluates therapeutic effects of FXR and TGR5 agonist in PSC

Results of a study presented today at the International Liver Congress 2010 demonstrate that a dual FXR and TGR5 agonist decreases liver damage and modulates hepatic inflammation and fibrosis in a mouse model of primary sclerosing chlolangitis. In contrast, selective FXR or TGR5 agonists have no beneficial effect.

19 Apr 2010

Results from Phase 2 study of BOTOX in IOAB patients presented at Anniversary EAU Congress

Treatment options for idiopathic OAB patients not adequately managed by anticholinergic therapy are limited; either highly invasive, expensive or of limited efficacy. BOTOX® (onabotulinumtoxinA) may provide a minimally invasive effective treatment. Professor Chris Chapple and his group conducted the first large, double-blind, placebo-controlled, dose ranging study to systematically asses the benefit/risk balance of the use of BOTOX® in IOAB across a wide range of doses.

19 Apr 2010

Patient advocates and researchers present MythBusters show to increase awareness of cancer research

Using a combination of "Jeopardy," "Saturday Night Live" and a famous Discovery Channel show called MythBusters, patient advocates and researchers at Vanderbilt Ingram Cancer Center presented "Mythbusters: Cancer Research in Jeopardy" to their community in an effort to increase awareness of cancer research, particularly clinical trials.

19 Apr 2010

Heart transplant patient skis to the North Pole

They made it! In what is believed to be a world-first, a heart transplant patient along with his transplant doctor skied over 100 miles, over ice, snow drifts, across open water, through gale-force winds and freezing temperatures to make it to the North Pole early Thursday morning.

17 Apr 2010

Racial disparities in sleep and health-related quality of life

A study in the April 15 issue of the Journal of Clinical Sleep Medicine shows that having a sleep disturbance is associated with clinically meaningful reductions in health-related quality of life, and the magnitude of this effect varies by race and sleep disorder.

17 Apr 2010

Touch, massage can reduce stress/anxiety, pain, fatigue, depression and nausea in cancer patients

Sponsored by the National Cancer Institute, a recent research study has revealed that touch and massage, routinely administered by care partners significantly reduces the effects of cancer and the side-effects from its treatment while providing comfort and improvement in the quality of life. During the study, family caregivers learned touch and massage techniques from an instructional DVD.

17 Apr 2010

Honey beneficial for treatment of fungating tumor wounds

Surviving cancer is physically and emotionally exhausting. But for many patients, beating the disease itself is just the first hurdle. A second ordeal comes from living with the fungating tumor wounds that accompany various cancers. Aside from the pain they inflict, these wounds often emit a strong and offensive odor. Not only does going into public become potentially embarrassing, but it also can be extremely depressing when even close family members are repulsed by the smell.

17 Apr 2010

MedImmune to present ten abstracts at American Association for Cancer Research meeting

MedImmune today announced that ten abstracts on progress being made in various oncology programs will be presented during the Annual Meeting of the American Association for Cancer Research in Washington, DC from April 17 to 21.

17 Apr 2010

700 scientists to present new information on smell and taste at AChemS 32nd annual meeting

The Association for Chemoreception Sciences (AChemS), a US-based scientific organization, is holding its 32nd annual meeting. About 700 scientists are gathering to present new information on the role of smell and taste in disease, nutrition and social interactions in humans as well as animals. Smell and taste play essential roles in our daily lives. These chemical senses serve as important warning systems, alerting us to the presence of potentially harmful situations or substances, including gas leaks, smoke, and spoiled food.

17 Apr 2010

More physical loading may delay disc degeneration: Research

Tapio Videman says back disorders in the working population are among the most costly illnesses in developed countries around the world. Disc degeneration is the main suspected origin of severe back symptoms and the main target in spine surgery. But Videman, a researcher in the University of Alberta's Faculty of Rehabilitation Medicine, wants to dispute the common perception that disc degeneration is caused by physical loading, the pressure put on the spine that comes with, for example, frequent lifting.

17 Apr 2010

WHO issues guidance on ash cloud from Iceland volcanic explosion

The ash cloud from the volcanic explosion in Iceland contains fine particles, similar to those emitted from other sources of particulate matter (PM); but as long as ash remains in the upper atmosphere, there will not likely be an increased risk of health effects, according to WHO.

17 Apr 2010

EAU honours urological experts at 25th Anniversary Congress

On 16 April 2010 the European Association of Urology opened its 25th Anniversary Congress. During the ceremony, several urological experts were honoured with awards for the outstanding work they did for the urological community. EAU Secretary General Per-Anders Abrahamsson handed them out.

17 Apr 2010

Access to NAbs testing important for MS therapy management

Teva Neuroscience today announced results at the 62nd American Academy of Neurology Annual Meeting which demonstrated that eliminating barriers to neutralizing antibodies (NAbs) testing significantly impacted multiple sclerosis (MS) treatment choices in patients receiving interferon beta (IFNβ) therapies.

17 Apr 2010

Lack of health insurance to delay emergency treatment during heart attack: Study

Lack of health insurance and financial worries about the cost of care contributed to as much as a six-hour delay in seeking emergency care for a heart attack, according to a first-of-its kind study published April 14 in the Journal of the American Medical Association.

17 Apr 2010

Extracorporeal liver support therapy valued as detoxification treatment option for patients with cirrhosis

Results from two studies presented today at the International Liver CongressTM 2010 have shown that treatment with extracorporeal devices may not confer a survival advantage for severe liver failure patients, despite positive dialysis effects. However, results among a small sub-group of patients show promise.

17 Apr 2010

Research roundup: Revamping NCI Clinical Trials, reducing malpractice suits, health disparities persist

A National Cancer Clinical Trials System For The 21st Century: Reinvigorating The NCI Cooperative Group Program - The "system for conducting cancer clinical trials in the United States is approaching a state of crisis," according to this report on inefficiencies and funding issues faced by the NCI's Clinical Trials Cooperative Group Program - which comprises 10 groups, more than 3,100 institutions, 14,000 investigators and more than 25,000 patients in clinical trials each year.

17 Apr 2010

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

The Translational Genomics Research Institute and Asuragen Inc. today announced a research agreement that could lead to ways of detecting cancer before it spreads.

17 Apr 2010

Medical Condition News

Results of BATTLE Trial presented at AACR 2010

Cell Therapeutics receives feedback regarding proposed filing of MAA for pixantrone

Organogenesis to showcase study results of Apligraf product at SAWC / WHS 2010

Study evaluates therapeutic effects of FXR and TGR5 agonist in PSC

Results from Phase 2 study of BOTOX in IOAB patients presented at Anniversary EAU Congress

Patient advocates and researchers present MythBusters show to increase awareness of cancer research

Heart transplant patient skis to the North Pole

Racial disparities in sleep and health-related quality of life

Touch, massage can reduce stress/anxiety, pain, fatigue, depression and nausea in cancer patients

Honey beneficial for treatment of fungating tumor wounds

MedImmune to present ten abstracts at American Association for Cancer Research meeting

700 scientists to present new information on smell and taste at AChemS 32nd annual meeting

More physical loading may delay disc degeneration: Research

WHO issues guidance on ash cloud from Iceland volcanic explosion

EAU honours urological experts at 25th Anniversary Congress

Access to NAbs testing important for MS therapy management

Lack of health insurance to delay emergency treatment during heart attack: Study

Extracorporeal liver support therapy valued as detoxification treatment option for patients with cirrhosis

Research roundup: Revamping NCI Clinical Trials, reducing malpractice suits, health disparities persist

TGen, Asuragen sign microRNA technology agreement for pancreatic cancer research

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News